Let's face it , even if money flows into rvx via a zenith deal we are still 4-5 years from completing BOM 2 - perhaps that fits pharmas timeline better? Zenith is in a different space allowing pharma to take a piece at a time without blowing apart their current interests in drug manipulation - realistically even if rvx gets 50-100 million between a zen deal & hepa the SP isn't going to go crazy with 4-5 years to solid proof , still a big gamble & going by rvx past performance on covid trials or doing anything with the many other compounds rvx has in its libary will continue to stay in hibernation imo. An all out buy out of both companies would be my preference & soon. Get the science where it belongs & out of the hands of these amateurs.